Company Filing History:
Years Active: 2017
Title: Tomomasa Shimanuki: Innovator in Cell Growth Identification
Introduction
Tomomasa Shimanuki is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of cellular biology, particularly in the identification of abnormal cell growth. His innovative methods have the potential to impact medical diagnostics and treatment.
Latest Patents
Shimanuki holds a patent for a method of identifying abnormal cells by expression levels of ETFB. This method provides a way to identify and suppress the abnormal growth of fibroblasts at an early stage. The process involves assessing the level of expression of ETFB (electron transfer flavoprotein beta subunit). When the ETFB expression level is high, it indicates a high probability of abnormal fibroblast growth. Conversely, a low level of ETFB suggests normal growth. Additionally, inhibiting ETFB can help suppress abnormal fibroblast growth. He has 1 patent to his name.
Career Highlights
Shimanuki's work at Pola Pharma Inc. has been instrumental in advancing research in cellular growth and its implications for health. His innovative approach to identifying fibroblast growth states showcases his expertise and commitment to improving medical diagnostics.
Collaborations
Some of his notable coworkers include Shigenari Hirokawa and Hiroyuki Kitajima. Their collaboration has likely contributed to the success of Shimanuki's research and innovations.
Conclusion
Tomomasa Shimanuki's contributions to the field of cellular biology through his patented methods highlight his role as an innovator. His work has the potential to enhance our understanding of cell growth and its implications for health.